Dr. Sridharan Rajaman did his PhD in Pharmacology and Toxicology at University of Vienna; since 2015 he is Principal Scientist at Amgen.
Guest Lecture: Novel Strategies for Atrial Fibrillation, Sept 3rd, 16:00, UZA2
20.08.2019
Related Links
- Science Careers beyond Academia See the interview with Dr. Sridharan Rajamani for the Biophysical Society (March 2019)
More News
15.04.2024
25.03.2024